-The Telegraph Ranchi: If cronyism and callousness led to the Bihar midday meal tragedy earlier this month, Jharkhand is staring at a credit crisis that is barely able to put food on plates in schools and anganwadis. Jharkhand's multi-crore food-for-children schemes - midday meal for schools and supplementary nutrition for anganwadis - are starved of funds and limping on credit, a survey conducted by the state adviser to the commissioner of Supreme...

-The United Nations The United Nations children's agency today commended the Government of Bangladesh for committing to end preventable child deaths in the country before 2035, building on its success of lowering maternal and child mortality. "There's a lot to learn from Bangladesh. Between 1991 and 2011, under-five deaths fell by almost 75 per cent, thanks, in part, to its commitment to innovation and knowledge-sharing," said UN Children's Fund (UNICEF) Executive Director...

-Down to Earth Is India ready to protect itself from the onslaught of food and nutrition industry? India is shouldering a huge burden of malnutrition-in the absence of government figures, a dipstick survey by non-profit HUNGaMA in 2012 suggests that 59 per cent of the country's children could have stunted growth and 42 per cent could be underweight. While the government is still struggling to tackle the problem, the food and nutrition...

-The Business Standard 7 things you should know in the Bhagwati vs Sen slugfest Jagdish Bhagwati and Amartya Sen are the two Indian economists who are most respected for their work. Both have worked on a broad spectrum of issues, though Sen is best known for his work on public choice and development and Bhagwati for his work on trade. They are both liberal, neoclassical economists, who support deregulation and disapprove of...

-The Hindu That the Union Health Ministry takes critical decisions affecting a large number of people without any scientific basis does not portend well for public Health in India. Neither the ban imposed on the oral anti-diabetes drug pioglitazone on June 18 nor its revocation a month later with a requirement that the medicine be sold with a boxed warning highlighting the adverse side-effect of bladder cancer was based on any...